Inappropriate data and measures lead to questionable conclusions: Reply

Archives of General Psychiatry

Volumn 70, Issue 1, 2013, Pages 122-123

  Gibbons, Robert D ^a   Brown, C Hendricks ^a,d   Hur, Kwan ^a,c   Davis, John M ^b   Mann, J John ^e,f  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c HINES VA HOSPITAL   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ATOMOXETINE; FLUOXETINE; VENLAFAXINE;

ATTENTION DEFICIT DISORDER; COMORBIDITY; DEPRESSION; GROUPS BY AGE; HUMAN; LETTER; SUICIDAL BEHAVIOR; SCIENTIFIC LITERATURE;

CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; FLUOXETINE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS; SUICIDE;

EID: 84873434510     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2013.749     Document Type: Letter

References (2)

1. Posner K, Oquendo MA, Gould M, Stanley B, Davies M. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry. 2007;164(7):1035-1043. (Pubitemid 47121392)
2. Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, Currier GW, Melvin GA, Greenhill L, Shen S, Mann JJ. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011; 168(12):1266-1277.